miR-335 suppresses metastasis and/or invasion in gastric and ovarian cancer by targeting Bcl-w [27, 28], and it inhibits small cell lung cancer metastasis by targeting IGF-IR and RANKL [26]. This evidence concerns the gene TNFSF11 and ovarian carcinoma.